These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Characterizing the effects of in utero valproic acid exposure on murine fetoplacental development. Shafique S; Winn LM Placenta; 2021 Sep; 112():141-152. PubMed ID: 34352490 [TBL] [Abstract][Full Text] [Related]
7. Clinical manifestation of prenatal exposure to valproic acid using case reports and epidemiologic information. Martínez-Frías ML Am J Med Genet; 1990 Oct; 37(2):277-82. PubMed ID: 2248297 [TBL] [Abstract][Full Text] [Related]
8. Valproic acid monotherapy in pregnancy and major congenital malformations. Jentink J; Loane MA; Dolk H; Barisic I; Garne E; Morris JK; de Jong-van den Berg LT; N Engl J Med; 2010 Jun; 362(23):2185-93. PubMed ID: 20558369 [TBL] [Abstract][Full Text] [Related]
9. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. Vajda FJ; O'brien TJ; Hitchcock A; Graham J; Cook M; Lander C; Eadie MJ J Clin Neurosci; 2004 Nov; 11(8):854-8. PubMed ID: 15519862 [TBL] [Abstract][Full Text] [Related]
10. Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta-analysis. Tanoshima M; Kobayashi T; Tanoshima R; Beyene J; Koren G; Ito S Clin Pharmacol Ther; 2015 Oct; 98(4):417-41. PubMed ID: 26044279 [TBL] [Abstract][Full Text] [Related]
12. [Influence of valproic acid (depakine I.V.) on human placenta metabolism--experimental model]. Semczuk-Sikora A; Rogowska W; Semczuk M Ginekol Pol; 2003 Aug; 74(8):596-602. PubMed ID: 14531336 [TBL] [Abstract][Full Text] [Related]
13. Valproic Acid in Women and Girls of Childbearing Age. Gotlib D; Ramaswamy R; Kurlander JE; DeRiggi A; Riba M Curr Psychiatry Rep; 2017 Sep; 19(9):58. PubMed ID: 28726062 [TBL] [Abstract][Full Text] [Related]
14. Valproic acid embryopathy: report of two siblings with further expansion of the phenotypic abnormalities and a review of the literature. Kozma C Am J Med Genet; 2001 Jan; 98(2):168-75. PubMed ID: 11223853 [TBL] [Abstract][Full Text] [Related]
15. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry. Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F; Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013 [TBL] [Abstract][Full Text] [Related]
16. Increased rate of major malformations in offspring exposed to valproate during pregnancy. Wyszynski DF; Nambisan M; Surve T; Alsdorf RM; Smith CR; Holmes LB; Neurology; 2005 Mar; 64(6):961-5. PubMed ID: 15781808 [TBL] [Abstract][Full Text] [Related]
17. Antiepileptic drug use during pregnancy: perinatal outcomes. Kulaga S; Sheehy O; Zargarzadeh AH; Moussally K; Bérard A Seizure; 2011 Nov; 20(9):667-72. PubMed ID: 21763158 [TBL] [Abstract][Full Text] [Related]
18. [Prenatal ultrasonographic diagnosis in the epileptic mother on valproic acid. Retrospective study of 161 cases in the central eastern France register of congenital malformations]. Bradaï R; Robert E J Gynecol Obstet Biol Reprod (Paris); 1998 Jun; 27(4):413-9. PubMed ID: 9690160 [TBL] [Abstract][Full Text] [Related]
19. Does folic acid use decrease the risk for spina bifida after in utero exposure to valproic acid? Jentink J; Bakker MK; Nijenhuis CM; Wilffert B; de Jong-van den Berg LT Pharmacoepidemiol Drug Saf; 2010 Aug; 19(8):803-7. PubMed ID: 20680999 [TBL] [Abstract][Full Text] [Related]
20. [Stigmata of dysembryogenesis and physical development in children born to mothers with epilepsy]. Kozhokaru AB; Karlov VA; Zhidkova IA; Serkina AV Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(5 Pt 2):52-7. PubMed ID: 23120790 [No Abstract] [Full Text] [Related] [Next] [New Search]